30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Elizabeth Reed

Track

Insider profile

Currently holds positions in Travere Therapeutics Inc and Anadys Pharmaceuticals Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, General Counsel and Corporate Secretary Travere Therapeutics Inc Jan. 4, 2017 -
Senior Vice President - Legal Affairs and General Counsel Anadys Pharmaceuticals Inc Aug. 1, 2009 -
Vice President, General Counsel, Secretary Eiger BioPharmaceuticals Inc June 1, 2014 - March 22, 2016
Elizabeth Reed's trades of Travere Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-05-06
PlS Planned sale
76,700 +39.7%
247.39
US$921,737 		76,700 +39.7% 247.39 US$921,737
2026-05-06 2026-05-06
PrS Proposed sale
73,722
342.87
US$4,310,657 		73,722 342.87 US$4,310,657
2026-05-06 2026-05-05
S Sale
21,063 +22.3%
214.34
US$4,108,700 		21,063 +22.3% 214.34 US$4,108,700
2026-05-05 2026-05-05
PrS Proposed sale
2,174
46.65
US$101,417 		2,174 46.65 US$101,417
2026-05-06 2026-05-04
PlS Planned sale
20,000 -16.0%
45.00
US$900,000 		20,000 -16.0% 45.00 US$900,000
2026-05-04 2026-05-04
PrS Proposed sale
20,000
45.00
US$900,000 		20,000 45.00 US$900,000
2026-04-15 2026-04-15
PlS Planned sale
1,559 -1.5%
42.53
US$66,304 		1,559 -1.5% 42.53 US$66,304
2026-04-15 2026-04-15
PlS Planned sale
5,226 -4.7%
41.62
US$217,506 		5,226 -4.7% 41.62 US$217,506
2026-04-15 2026-04-15
PrS Proposed sale
6,785
41.83
US$283,823 		6,785 41.83 US$283,823
2026-04-15 2026-04-14
S Sale
7,215 -6.1%
41.93
US$302,516 		7,215 -6.1% 41.93 US$302,516
2026-04-15 2026-04-14
PlS Planned sale
37,500 -23.9%
41.07
US$1,540,125 		37,500 -23.9% 41.07 US$1,540,125
2026-04-14 2026-04-14
PrS Proposed sale
7,215
41.93
US$302,516 		7,215 41.93 US$302,516
2026-04-14 2026-04-14
PrS Proposed sale
37,500
41.07
US$1,540,125 		37,500 41.07 US$1,540,125
2026-04-02 2026-04-01
PlS Planned sale
10,000 -8.7%
30.00
US$300,000 		10,000 -8.7% 30.00 US$300,000
2026-04-02 2026-04-01
PlS Planned sale
10,000 -8.7%
30.00
US$300,000 		10,000 -8.7% 30.00 US$300,000
2026-04-01 2026-04-01
PrS Proposed sale
10,000
30.00
US$300,000 		10,000 30.00 US$300,000
2026-03-18 2026-03-16
PlS Planned sale
10,000 -8.7%
28.09
US$280,861 		10,000 -8.7% 28.09 US$280,861
2026-03-16 2026-03-16
PrS Proposed sale
10,000
28.09
US$280,861 		10,000 28.09 US$280,861
2026-02-19 2026-02-17
PlS Planned sale
4,321 -3.9%
28.26
US$122,120 		4,321 -3.9% 28.26 US$122,120
2026-02-19 2026-02-17
PlS Planned sale
5,679 -4.9%
27.50
US$156,195 		5,679 -4.9% 27.50 US$156,195
2026-02-17 2026-02-17
PrS Proposed sale
10,000
27.83
US$278,317 		10,000 27.83 US$278,317
2026-02-05 2026-02-04
PlS Planned sale
509 -0.5%
32.74
US$16,665 		509 -0.5% 32.74 US$16,665
2026-02-05 2026-02-04
PlS Planned sale
2,485 -2.3%
32.07
US$79,694 		2,485 -2.3% 32.07 US$79,694
2026-02-04 2026-02-04
PrS Proposed sale
2,994
32.18
US$96,360 		2,994 32.18 US$96,360
2026-02-03 2026-02-03
S Sale
7,175 -6.2%
32.12
US$230,461 		7,175 -6.2% 32.12 US$230,461
2026-02-03 2026-02-03
PrS Proposed sale
7,175
32.12
US$230,464 		7,175 32.12 US$230,464
2026-02-03 2026-02-03
S Sale
7,175 -6.2%
32.12
US$230,461 		7,175 -6.2% 32.12 US$230,461
2026-01-21 2026-01-20
PlS Planned sale
10,000 -10.0%
27.34
US$273,420 		10,000 -10.0% 27.34 US$273,420
2026-01-20 2026-01-20
PrS Proposed sale
10,000
27.34
US$273,420 		10,000 27.34 US$273,420
2025-09-24 2025-09-22
PlS Planned sale
10,000 -10.0%
25.00
US$250,000 		10,000 -10.0% 25.00 US$250,000
2025-09-22 2025-09-22
PrS Proposed sale
10,000
25.00
US$250,000 		10,000 25.00 US$250,000
2025-05-05 2025-05-05
PrS Proposed sale
4,920
21.05
US$103,566 		4,920 21.05 US$103,566
2025-05-05 2025-05-05
PlS Planned sale
4,920 -5.2%
21.05
US$103,566 		4,920 -5.2% 21.05 US$103,566
2025-02-12 2025-02-12
PrS Proposed sale
8,000
23.53
US$188,240 		8,000 23.53 US$188,240
2025-02-12 2025-02-12
PlS Planned sale
8,000 -8.2%
23.53
US$188,240 		8,000 -8.2% 23.53 US$188,240
2025-02-04 2025-02-03
PlS Planned sale
8,951 -9.1%
19.78
US$177,051 		8,951 -9.1% 19.78 US$177,051
2025-02-03 2025-02-03
PrS Proposed sale
8,951
19.78
US$177,051 		8,951 19.78 US$177,051
2025-01-23 2025-01-22
PlS Planned sale
2,437 -3.1%
19.46
US$47,424 		2,437 -3.1% 19.46 US$47,424
2025-01-22 2025-01-22
PrS Proposed sale
2,437
19.46
US$47,424 		2,437 19.46 US$47,424
2024-09-09 2024-09-09
PrS Proposed sale
4,387
11.52
US$50,538 		4,387 11.52 US$50,538
2024-09-09 2024-09-09
PlS Planned sale
4,387 -5.3%
11.52
US$50,538 		4,387 -5.3% 11.52 US$50,538
2024-02-02 2024-02-01
PlS Planned sale
2,590 -3.3%
8.86
US$22,947 		2,590 -3.3% 8.86 US$22,947
2024-02-02 2024-02-01
S Sale
2,174 -2.7%
8.53
US$18,548 		2,174 -2.7% 8.53 US$18,548
2024-02-01 2024-02-01
PrS Proposed sale
2,590
8.86
US$22,947 		2,590 8.86 US$22,947
2024-02-01 2024-02-01
PrS Proposed sale
2,174
8.53
US$18,548 		2,174 8.53 US$18,548